Morgan Stanley, Nuvama & more: Stock recommendations by brokers for today — check details
BoFA Securities has a buy rating on Varun Beverages with the target price at Rs 550. Analysts said that VBL has acquired Twizza, the no 4 player in South Africa, enhancing production capacity with its three backward integrated facilities. This complements the company’s manufacturing footprint and strengthens VBL’s market position. The deal was done at an attractive valuation that adds 6% to VBL volume, 4% to its revenue and 2% to its earnings before interest, taxes, depreciation, and amortisation (EBITDA). Overall execution and delivery next summer are the key for the company.Nuvama has a buy rating on Century Plywood with the target price at Rs 1,028. Analysts said that the company’s management was confident of achieving Rs 12,000 crore revenue by FY31 targeting 18% compounded annual growth rate (CAGR). The company can achieve Rs 700 crore – Rs 750 crore revenue from the current gross block and will need further Rs 2,000 crore – Rs 2,500 crore investment by FY29 to achieve FY31 target. The company also said that its plywood execution was strong, while medium-density fibreboard (MDF) margins shall turn around H2FY27 onwards, laminates turnaround is in progress, and particle board to record EBITDA breakeven by Q3FY26.Nomura has a buy on Samvardhana Motherson with the target price at Rs 125. Analysts said that the company is acquiring Nexans Auto’s wiring harness business through which it’s set to foray into the global photovoltaic wiring harness segment with an attractive acquisition. They expect the potential transaction to be cash earnings per share (EPS)-accretive. Analysts believe the acquisition is attractively valued and could potentially lead to EPS accretion of 2% in the first year itself.Morgan Stanley has initiated its coverage of Pine Labs with an equal weight rating and the target price at Rs 260. Analysts said that the company is a leader in its focus segments, benefits from first mover advantage and a strong partner ecosystem. They projected a 19% revenue CAGR for FY25-FY28 and expect its shift towards an asset-light model to drive EBIT margin to 20% by FY28 (against 3% in FY25).Investec has initiated its buy rating on Canara HSBC Life Insurance with a buy rating and a target price of Rs 225. Analysts said that the stock is a mispriced opportunity as it’s a relatively low-risk way to play the structural life insurance growth story in India. The visible drivers for margin expansion and distribution-led scale are present. Its current valuations imply only modest value of new business (VNB) growth.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)
